5Blanchet M, Sureau C. Infectivity determinants of the hepatitis B virus pre-S domain are confined to the N-terminal 75 amino acid residues. J Virol, 2007,81 : 5841-5849. 被引量：1
6Dash S, Rao KV, Panda SK. Receptor for pre-S1 ( 21-47 ) component of hepatitis B virus on the liver cell:role in virus cell interaction. J Med Virol, 1992,37 : 116-121. 被引量：1
7Zhou X, Huang L. DNA transfection mediated by cationic liposomes containing lipopolylysine: characterization and mechanism of action. Biochim Biophys Acta, 1994,1189 : 195-203. 被引量：1
8Miller AD. The problem with cationic liposome/micelle-based non-viral vector systems for gene therapy. Curr Med Chem,2003,10:1195- 1211. 被引量：1
9Davis SS. Biomedical applications of nanotechnology-implications for drug targeting and gene therapy. Trends Biotechnol, 1997,15 : 217- 224. 被引量：1
10Holzer GW, Mayrhofer J, Leitner J et al. Overexpression of hepatitis B virus surface antigens including the preS1 region in a serum-free Chinese hamster ovary cell line. Protein Expr Purif,2003 ,29 :58-69. 被引量：1
